Gout.
Dalbeth N, Gosling AL, Gaffo A, Abhishek A.
Lancet. 2021 May 15;397(10287):1843-1855. doi: 10.1016/S0140-6736(21)00569-9. Epub 2021 Mar 30.
[Gout arthritis: Pathogenesis, diagnostics and treatment].
Keyßer G.
Dtsch Med Wochenschr. 2020 Jul;145(14):991-1005. doi: 10.1055/a-1036-8348. Epub 2020 Jul 15.
Environmental Triggers of Hyperuricemia and Gout.
Helget LN, Mikuls TR.
Rheum Dis Clin North Am. 2022 Nov;48(4):891-906. doi: 10.1016/j.rdc.2022.06.009.
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention.
Yokose C, McCormick N, Choi HK.
Curr Rheumatol Rep. 2021 Jul 1;23(7):51. doi: 10.1007/s11926-021-01020-y.
Mechanisms and rationale for uricase use in patients with gout.
Schlesinger N, Pérez-Ruiz F, Lioté F.
Nat Rev Rheumatol. 2023 Oct;19(10):640-649. doi: 10.1038/s41584-023-01006-3. Epub 2023 Sep 8.
Establishment and Validation of Predictive Model of Tophus in Gout Patients.
Lei T, Guo J, Wang P, Zhang Z, Niu S, Zhang Q, Qing Y.
J Clin Med. 2023 Feb 22;12(5):1755. doi: 10.3390/jcm12051755.
TET2-mutant clonal hematopoiesis and risk of gout.
Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, Wong WJ, Weeks LD, Lin AE, Miller PG, Gibson CJ, Sekar A, Schaefer IM, Neuberg D, Stone RM, Bick AG, Uddin MM, Griffin GK, Jaiswal S, Natarajan P, Nigrovic PA, Rao DA, Ebert BL.
Blood. 2022 Sep 8;140(10):1094-1103. doi: 10.1182/blood.2022015384.
Lead nephropathy, gout, and hypertension.
Batuman V.
Am J Med Sci. 1993 Apr;305(4):241-7. doi: 10.1097/00000441-199304000-00008.
Tophaceous Gout.
Liu Y, Jiao Y.
Clin Case Rep. 2025 Feb 20;13(2):e70262. doi: 10.1002/ccr3.70262. eCollection 2025 Feb.
Hyperuricemia and Cardiovascular Disease.
Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W, Zhang D.
Curr Pharm Des. 2019;25(6):700-709. doi: 10.2174/1381612825666190408122557.
